Saadettin Kilickap,1 Ahmet Sezer,2 Mahmut Gümüş,3 Igor Bondarenko,4 Mustafa Özgüroğlu,5 Miranda Gogishvili,6 Haci M Turk,7 Irfan Cicin,8 Dmitry Bentsion,9 Oleg Gladkov,10 Philip Clingan,11 Virote Sriuranpong,12 Naiyer Rizvi,13 Siyu Li,14 Sue Lee,14 Tamta Makharadze,15 Semra Paydas,16 Marina Nechaeva,17 Frank Seebach,18 David M Weinreich,18 George D Yancopoulos,18
Giuseppe Gullo,18 Israel Lowy,18 Petra Rietschel18
1Department of Medical Oncology, Hacettepe University Institute of Cancer, Ankara, Turkey; 2Department of Medical Oncology, Başkent University, Adana, Turkey; 3Department of Medical Oncology, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey; 4Department of Oncology and Medical Radiology, Dnipropetrovsk Medical Academy, Dnipro, Ukraine; 5Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey; 6High Technology Medical Centre, University Clinic Ltd, Tbilisi, Georgia; 7Department of Medical Oncology, Bezmialem Vakif University, Medical Faculty, Istanbul, Turkey; 8Department of Medical Oncology, Trakya University, Edirne, Turkey; 9Sverdlovsk Regional Oncology Centre, Sverdlovsk, Russia; 10LLC, “EVIMED”, Chelyabinsk, Russia; 11Southern Medical Day Care Centre and Illawarra Health and Medical Research Institute, University of Wollongong/Illawarra Cancer Centre, Wollongong Hospital, Wollongong, New South Wales, Australia; 12Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand; 13Division of Hematology/Oncology, Columbia University Medical Center, New York, New York, USA; 14Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey, USA; 15LTD High Technology Hospital Medcenter, Batumi, Georgia; 16Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey; 17Arkhangelsk Clinical Oncology Center, Arkhangelsk, Russia; 18Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA